N
News Analysis
dailypolitical.com

www.dailypolitical.com ·

Positive

compass therapeutics cmpx expected to announce quarterly earnings on thursday

TAX_ECON_PRICETAX_DISEASE_TUMORSEIGECHECKPOINT

All NewsRead the full story on dailypolitical.com

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

Earnings announcement for a clinical-stage biotech company with no approved products; no commercial mechanism beyond routine financial reporting. No concrete revenue, cost, or supply chain impact identified. Sector PHARMA_BIOTECH included due to company's primary business, but commercial signal is weak.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.

  • Compass Therapeutics (CMPX) to report Q1 2026 earnings on May 14, 2026.
  • Analysts expect EPS loss of $0.10 and revenue of $0.818 million.
  • Previous quarter EPS was ($0.10), in line with expectations.
  • Stock price $1.83, market cap $329.56 million, 52-week range $1.61-$6.88.
  • Consensus rating 'Moderate Buy' with average price target $13.60.

About the publisher

gdelt_bigquery is one of the en-language news outlets that News Analysis aggregates. Coverage from this source appears in our global feed alongside the publisher's own reporting.

Topic context

gdelt_bigquery files this story under "tax econ price" in the GDELT knowledge graph. News Analysis surfaces coverage based on the same open classification taxonomy.

compass therapeutics cmpx expected to announce quarterly earnings on thursday | dailypolitical.com — News Analysis